COMPUS Communiqué – Vol. 4, No. 5

In This Issue

• Diabetes Management Topic Area
• Next Steps for the Insulin Analogues Project
• Employment Opportunities
• Feedback

Diabetes Management Topic Area

The Canadian Agency for Drugs and Technologies in Health (CADTH), through its Canadian Optimal Medication Prescribing and Utilization Service (COMPUS), is producing a series of optimal therapy reports on the insulin analogues component of our diabetes management topic area. Today, one additional report has been posted on our web site:

Economic Report

Thank you for your feedback on the economic assessment that was undertaken to determine the cost-effectiveness of insulin analogues, relative to human insulin, in the management of individuals with type 1 and type 2 diabetes mellitus in Canada. COMPUS and the COMPUS Expert Review Committee considered your feedback in the production of the final report. This report, Canadian Agency for Drugs and Technologies in Health. An Economic Evaluation of Insulin Analogues for the Treatment of Patients with Type 1 and Type 2 Diabetes Mellitus in Canada. Optimal Therapy Reports − COMPUS 2008;2(4) is now available.

Next Steps for the Insulin Analogues Project

Draft Optimal Therapy Recommendations Report

CADTH will soon be inviting you to provide input on its Draft Optimal Therapy Recommendations Report on Insulin Analogues. This report is currently being reviewed by our COMPUS Expert Review and COMPUS Advisory Committees.

Employment Opportunities

Research Assistant-COMPUS (One-year Term)

CADTH has many exciting job openings. If you’re interested in joining our growing team of professionals, visit Careers/Job Listings.

Feedback

We welcome your feedback. Tell us what you think of the COMPUS Communiqué.